Expert centers, university hospitals, pharmaceutical laboratories, CROs

YOUR NEEDS

OUR NON-INVASIVE MASH DIAGNOSTIC TEST IS USED IN THE DIAGNOSIS AND MONITORING OF PATIENTS AT RISK OF BEING CARRIERS OF MASH

ELiBio is a software solution dedicated to characterize liver health in patients suffering from metabolic liver diseases such as MAFLD (Metabolic-Associated Fatty Liver Disease) and MASH (Metabolic Dysfunction-Associated Steatohepatitis). It allows clinicians to visualize, measure, and monitor liver tissue composition (3D fat & iron content and 3D fibrosis presence and severity) from a single hold breathing MRI scan lasting less than 20 seconds.

WHO IS OUR SOLUTION FOR?

Expert Centers, University Hospitals

Access to clear and easily interpretable visual reports allows doctors to:

  • Make an initial diagnosis of MASH and distinguish it from simple steatosis
  • Identify patients likely to benefit from pharmacological treatment
  • Monitor the patient and evaluate the effectiveness of treatment, whether pharmacological or dietary)

Pharmaceutical companies and CROs

ELiBio technology can be used in therapeutic trials to assess the impact of a drug candidate or treatment on the liver.

In addition, ELiBio enables the generation of maps of fat composition (polyunsaturated, monounsaturated, saturated) as well as intra-abdominal to subcutaneous fat ratio.

Designed for University Hospital, Expert center on liver diseases, Pharmaceutical companies and CROs

MORE INFO
ELiBio Software

    WANT TO LEARN MORE ?

    Contact ELiBio team

    Je prends rendez-vous !
    Need a demo?
    Get in touch with us!